Literature DB >> 28189355

Outcome predictors in median arcuate ligament syndrome.

Kelvin Kam Fai Ho1, Philip Walker2, B Mark Smithers3, Wallace Foster4, Leslie Nathanson4, Nicholas O'Rourke4, Ian Shaw5, Timothy McGahan6.   

Abstract

BACKGROUND: Median arcuate ligament syndrome (MALS) is a condition characterized by chronic abdominal symptoms associated with median arcuate ligament compression of the celiac artery. The selection of patients is difficult in the management of MALS. This study aimed to identify factors that predict outcomes of surgical and nonoperative treatment in these patients.
METHODS: Patients referred with a possible diagnosis of MALS between 1998 and 2013 were identified retrospectively. Only patients with chronic symptoms and radiologically confirmed celiac artery compression were included. The clinical features, investigations, and management were documented. Outcome was assessed using the Visick score, Gastrointestinal Symptom Rating Scale, and 12-Item Short Form Health Survey by telephone interview and review of medical records.
RESULTS: There were 67 patients, 43 (64%) treated surgically and 24 (36%) managed without surgery, with a median follow-up of 25 months and 24 months, respectively. After surgical treatment, 16 (37%) were asymptomatic, 24 (56%) were partially improved, 3 (7%) had no changes in symptoms, and none had worsening of symptoms. Postexertional pain predicted improvement after surgery (P = .022). Vomiting (P = .046) and unprovoked pain (P = .006) were predictors of poor surgical outcome. After nonoperative management, 1 (4%) was asymptomatic, 7 (29%) were partially improved, 12 (50%) had no changes in symptoms, and 4 (17%) had worsening of symptoms. No outcome predictors of nonoperative treatment were identified.
CONCLUSIONS: MALS was more likely to respond to decompression if patients had postexertional pain. Patients who presented with vomiting and unprovoked pain were unlikely to respond to surgery. In contrast with previous studies, postprandial pain was not found to be predictive of outcome. Crown
Copyright © 2016. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28189355     DOI: 10.1016/j.jvs.2016.11.040

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  8 in total

1.  Short- and intermediate-term clinical outcome comparison between laparoscopic and robotic-assisted median arcuate ligament release.

Authors:  Usah Khrucharoen; Yen-Yi Juo; Yijun Chen; Juan C Jimenez; Erik P Dutson
Journal:  J Robot Surg       Date:  2019-03-21

2.  Gelatinous bone marrow transformation due to extensive weight loss in median arcuate ligament syndrome.

Authors:  Lorena Miguelañez Matute; Desiree van Noord; Nazik Rayman; Samara S Guillen
Journal:  BMJ Case Rep       Date:  2022-01-17

3.  Severe Post-prandial Pain: A Case Report.

Authors:  Nandita Kakar; Harrison C Smith; David L Crawford; Anthony M Shadid
Journal:  Cureus       Date:  2022-02-21

4.  Robotic Surgery for Median Arcuate Ligament Syndrome.

Authors:  Colton Fernstrum; Michael Pryor; G Paul Wright; Andrea M Wolf
Journal:  JSLS       Date:  2020 Apr-Jun       Impact factor: 2.172

5.  An unusual cause of epigastric pain and diaphoresis.

Authors:  Vivian Georgopoulou; Evgenia Gouridou; Athina Pyrpasopoulou; Andreana Kozanidou; Christodoulos Papadopoulos; Stergios Tzikas; Maria Sidiropoulou
Journal:  Heliyon       Date:  2020-02-28

6.  Two Decades of Experience With Chronic Mesenteric Ischaemia and Median Arcuate Ligament Syndrome in a Tertiary Referral Centre: A Parallel Longitudinal Comparative Study.

Authors:  Sherif A Sultan; Yogesh Acharya; Mohamed Mustafa; Niamh Hynes
Journal:  Cureus       Date:  2021-12-27

7.  Median Arcuate Ligament Syndrome Masquerading as Functional Abdominal Pain Syndrome.

Authors:  Michael Scharf; Kaitlyn A Thomas; Niteesh Sundaram; Shri Jai Kirshan Ravi; Mustafa Aman
Journal:  Cureus       Date:  2021-12-21

8.  A diagnostic workup and laparoscopic approach for median arcuate ligament syndrome.

Authors:  Jason Diab; Vanessa Diab; Christophe R Berney
Journal:  ANZ J Surg       Date:  2022-02-01       Impact factor: 2.025

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.